{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:16:02Z","timestamp":1786979762781,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00210-022-02337-w","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T05:03:34Z","timestamp":1670562214000},"page":"803-809","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacokinetics and bioequivalence evaluation of 2 oral formulations of methotrexate tablets in healthy Chinese volunteers under fasting and fed conditions"],"prefix":"10.1007","volume":"396","author":[{"given":"Xu","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiandong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"key":"2337_CR1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","volume":"14","author":"JL Alexander","year":"2017","unstructured":"Alexander JL, Wilson ID, Teare J, Marchesi JR, Nicholson JK, Kinross JM (2017) Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol 14:356\u2013365. https:\/\/doi.org\/10.1038\/nrgastro.2017.20","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2337_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrrheum.2010.5","volume":"6","author":"ES Chan","year":"2010","unstructured":"Chan ES, Cronstein BN (2010) Methotrexate\u2013how does it really work? Nat Rev Rheumatol 6:175\u2013178. https:\/\/doi.org\/10.1038\/nrrheum.2010.5","journal-title":"Nat Rev Rheumatol"},{"key":"2337_CR3","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0, 2017."},{"key":"2337_CR4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/s0889-857x(05)70358-6","volume":"23","author":"BN Cronstein","year":"1997","unstructured":"Cronstein BN (1997) The mechanism of action of methotrexate. Rheum Dis Clin North Am 23:739\u2013755. https:\/\/doi.org\/10.1016\/s0889-857x(05)70358-6","journal-title":"Rheum Dis Clin North Am"},{"key":"2337_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1124\/pr.57.2.3","volume":"57","author":"BN Cronstein","year":"2005","unstructured":"Cronstein BN (2005) Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol Rev 57:163\u2013172. https:\/\/doi.org\/10.1124\/pr.57.2.3","journal-title":"Pharmacol Rev"},{"key":"2337_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","volume":"16","author":"BN Cronstein","year":"2020","unstructured":"Cronstein BN, Aune TM (2020) Methotrexate and its mechanisms of action in inflammatory arthritis. Nat Rev Rheumatol 16:145\u2013154. https:\/\/doi.org\/10.1038\/s41584-020-0373-9","journal-title":"Nat Rev Rheumatol"},{"key":"2337_CR7","unstructured":"EMA, Assessment report: methotrexate (EB\/OL), 2019. https:\/\/www.ema.europa.eu\/en\/documents\/referral\/methotrexate-article-31-referral-public-assessment-report-emea\/h\/31\/1463_en.pdf"},{"key":"2337_CR8","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1021\/acs.jafc.8b00456","volume":"66","author":"D Ercolini","year":"2018","unstructured":"Ercolini D, Fogliano V (2018) Food design to feed the human gut microbiota. J Agric Food Chem 66:3754\u20133758. https:\/\/doi.org\/10.1021\/acs.jafc.8b00456","journal-title":"J Agric Food Chem"},{"key":"2337_CR9","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1080\/19490976.2018.1527167","volume":"10","author":"A Elkrief","year":"2019","unstructured":"Elkrief A, Derosa L, Zitvogel L, Kroemer G, Routy B (2019) The intimate relationship between gut microbiota and cancer immunotherapy. Gut Microbes 10:424\u2013428. https:\/\/doi.org\/10.1080\/19490976.2018.1527167","journal-title":"Gut Microbes"},{"key":"2337_CR10","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/rheumatology\/keh297","volume":"43","author":"J Fransen","year":"2004","unstructured":"Fransen J, Creemers MC, Van Riel PL (2004) Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology (oxford) 43:1252\u20131255. https:\/\/doi.org\/10.1093\/rheumatology\/keh297","journal-title":"Rheumatology (oxford)"},{"key":"2337_CR11","unstructured":"FDA, Guidance on Methotrexate Sodium (EB\/OL), 2011\u201310. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/psg\/Methotrexate%20Sodium_final_Oral%20tab_RLD%2008085_RC10-11.pdf"},{"key":"2337_CR12","unstructured":"FDA, Xatmep\u00ae (Methotrexate oral solution) Clinical review(s) (EB\/OL), 2017\u201303. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/008085s066lbl.pdf"},{"key":"2337_CR13","unstructured":"FDA, METHOTREXATE 2.5 mg Label (EB\/OL), DAVA Pharmaceuticals Inc, 2018. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2017\/208400Orig1Orig2s000MedR.pdf"},{"key":"2337_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2022.102227","volume":"64","author":"CM Garc\u00eda-Gonz\u00e1lez","year":"2022","unstructured":"Garc\u00eda-Gonz\u00e1lez CM, Baker J (2022) Treatment of early rheumatoid arthritis: methotrexate and beyond. Curr Opin Pharmacol 64:102227. https:\/\/doi.org\/10.1016\/j.coph.2022.102227","journal-title":"Curr Opin Pharmacol"},{"key":"2337_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.critrevonc.2019.09.003","volume":"143","author":"S Gori","year":"2019","unstructured":"Gori S, Inno A, Belluomini L, Bocus P, Bisoffi Z, Russo A, Arcaro G (2019) Gut microbiota and cancer: how gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy. Crit Rev Oncol Hematol 143:139\u2013147. https:\/\/doi.org\/10.1016\/j.critrevonc.2019.09.003","journal-title":"Crit Rev Oncol Hematol"},{"key":"2337_CR16","first-page":"630","volume":"22","author":"RA Hamilton","year":"1995","unstructured":"Hamilton RA, Kremer JM (1995) The effects of food on methotrexate absorption. J Rheumatol 22:630\u2013632","journal-title":"J Rheumatol"},{"key":"2337_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.839015","volume":"13","author":"M Han","year":"2022","unstructured":"Han M, Zhang N, Mao Y, Huang B, Ren M, Peng Z, Bai Z, Chen L, Liu Y, Wang S, Huang S, Cheng Z (2022) The potential of gut microbiota metabolic capability to detect drug response in rheumatoid arthritis patients. Front Microbiol 13:839015. https:\/\/doi.org\/10.3389\/fmicb.2022.839015","journal-title":"Front Microbiol"},{"key":"2337_CR18","volume":"11","author":"D Hossein","year":"2016","unstructured":"Hossein D, Mehrdad H (2016) Pharmacokinetics and bioequivalence of methotrexate in human plasma studied by liquid chromatography-mass spectrometry (LC-MS). Jundishapur J Nat Pharm Prod 11:e36758","journal-title":"Jundishapur J Nat Pharm Prod"},{"key":"2337_CR19","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/art.1780350708","volume":"35","author":"GD Kozloski","year":"1992","unstructured":"Kozloski GD, De Vito JM, Kisicki JC, Johnson JB (1992) The effect of food on the absorption of methotrexate sodium tablets in healthy volunteers. Arthritis Rheum 35:761\u2013764. https:\/\/doi.org\/10.1002\/art.1780350708","journal-title":"Arthritis Rheum"},{"key":"2337_CR20","doi-asserted-by":"publisher","unstructured":"Lopez-Olivo MA, Siddhanamatha HR, Shea B, Tugwell P, Wells GA, Suarez-Almazor ME (2014) Methotrexate for treating rheumatoid arthritis. Cochrane Database Syst Rev 2014:CD000957. https:\/\/doi.org\/10.1002\/14651858.CD000957.pub2.","DOI":"10.1002\/14651858.CD000957.pub2"},{"key":"2337_CR21","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1111\/bcp.14057","volume":"85","author":"CJ Lucas","year":"2019","unstructured":"Lucas CJ, Dimmitt SB, Martin JH (2019) Optimising low-dose methotrexate for rheumatoid arthritis-A review. Br J Clin Pharmacol 85:2228\u20132234. https:\/\/doi.org\/10.1111\/bcp.14057","journal-title":"Br J Clin Pharmacol"},{"key":"2337_CR22","first-page":"279","volume":"55","author":"F Madanat","year":"1987","unstructured":"Madanat F, Awidi A, Shaheen O, Othman S, Al-Turk W (1987) Effects of food and gender on the pharmacokinetics of methotrexate in children. Res Commun Chem Pathol Pharmacol 55:279\u2013282","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"2337_CR23","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","volume":"389","author":"IB McInnes","year":"2017","unstructured":"McInnes IB, Schett G (2017) Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet 389:2328\u20132337. https:\/\/doi.org\/10.1016\/S0140-6736(17)31472-1","journal-title":"Lancet"},{"key":"2337_CR24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2165\/00003088-197803050-00001","volume":"3","author":"A Melander","year":"1978","unstructured":"Melander A (1978) Influence of food on the bioavailability of drugs. Clin Pharmacokinet 3:337\u2013351. https:\/\/doi.org\/10.2165\/00003088-197803050-00001","journal-title":"Clin Pharmacokinet"},{"key":"2337_CR25","unstructured":"MHRA, Public Assessment Report. Decentralised procedure. Methotrexate 2.5 mg, 10 mg tablets (EB\/OL), 2001."},{"key":"2337_CR26","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2165\/00003495-200262100-00005","volume":"62","author":"LE Schmidt","year":"2002","unstructured":"Schmidt LE, Dalhoff K (2002) Food-drug interactions. Drugs 62:1481\u20131502. https:\/\/doi.org\/10.2165\/00003495-200262100-00005","journal-title":"Drugs"},{"key":"2337_CR27","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388:2023\u20132038. https:\/\/doi.org\/10.1016\/S0140-6736(16)30173-8","journal-title":"Lancet"},{"key":"2337_CR28","first-page":"S40","volume":"34","author":"PL van Riel","year":"2016","unstructured":"van Riel PL, Renskers L (2016) The Disease Activity Score (DAS) and the Disease Activity Score using 28 joint counts (DAS28) in the management of rheumatoid arthritis. Clin Exp Rheumatol 34:S40\u2013S44","journal-title":"Clin Exp Rheumatol"},{"key":"2337_CR29","doi-asserted-by":"publisher","unstructured":"Yarris JP, Roy HAJ, Hertz MD, (1909\u20132002), (2003) The cure of choriocarcinoma and its impact on the development of chemotherapy for cancer. Gynecol Oncol 89:193\u2013198. https:\/\/doi.org\/10.1016\/s0090-8258(03)00110-0","DOI":"10.1016\/s0090-8258(03)00110-0"},{"key":"2337_CR30","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s10787-020-00741-3","volume":"28","author":"J Yu","year":"2020","unstructured":"Yu J, Zhou P (2020) The advances of methotrexate resistance in rheumatoid arthritis. Inflammopharmacology 28:1183\u20131193. https:\/\/doi.org\/10.1007\/s10787-020-00741-3","journal-title":"Inflammopharmacology"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-022-02337-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-022-02337-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-022-02337-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:05:13Z","timestamp":1679875513000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-022-02337-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["2337"],"URL":"https:\/\/doi.org\/10.1007\/s00210-022-02337-w","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,9]]},"assertion":[{"value":"9 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol and informed consent documents were approved by the Ethics Committee of Xinxiang Central Hospital (2019\u2013072 and 2021\u2013024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all participates.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"No identifying details in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}